Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs

Details for Australian Patent Application No. 2010210403 (hide)

Owner The Board of Trustees of the University of Illinois

Inventors Hergenrother, Paul Joseph; Peterson, Quinn Patrick; Hsu, Danny Chung; West, Diana C.; Fan, Timothy M.; Novotny, Chris J.

Agent FB Rice

Pub. Number AU-A-2010210403

PCT Pub. Number WO2010/091382

Priority 61/151,064 09.02.09 US

Filing date 9 February 2010

Wipo publication date 12 August 2010

International Classifications

C07D 295/15 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/091382 Priority application(s): WO2010/091382

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210404-Inflatable minimally invasive system for delivering and securing an annular implant

2010210398-Spring orthotic device